Search alternatives:
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), teer decrease (Expand Search)
c decrease » c decreased (Expand Search), _ decrease (Expand Search), rc decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
961
-
962
-
963
-
964
-
965
-
966
-
967
-
968
-
969
-
970
The phagocytosis of polystyrene beads was most significantly decreased by anti-CD36 antibodies.
Published 2013“…GA 31.25 µg/ml are indicated by asterisks (*p<0.05, **p<0.01, and ***p<0.001 using Bonferroni's Multiple Comparison Test) as determined by one-way ANOVA. <b>B–C.</b> The anti-CD36 antibodies of two different clones show a diverse impact on the phagocytosis of polystyrene beads by untreated cells, whereas both antibodies effectively decreased the GA induced phagocytosis.…”
-
971
-
972
Disruption of bacterial K<sup>+</sup> homeostasis decreases Mtb colonization of macrophages.
Published 2019“…(B and C) Mtb Δ<i>ceoBC</i> mutant exhibits decreased <i>rv2390c’</i>::GFP induction response during macrophage infection. …”
-
973
-
974
-
975
-
976
Nilotinib decreases HEI-193 cell viability in a time-, dose-, and growth condition- dependent manner.
Published 2013“…(B) HEI-193 grown in PDGF media were treated with 0, 3, 5, 10 or 20 µM nilotinib up to 5 days. Trypan blue viability assay shows decreased number of viable cells at 5 days in 3 µM nilotinib, compared to vehicle shown, mean and SD of six technical replicates. …”
-
977
Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism-7
Published 2011“…<p><b>Copyright information:</b></p><p>Taken from "Fibrinogen decreases cardiomyocyte contractility through an ICAM-1-dependent mechanism"</p><p>http://ccforum.com/content/12/1/R2</p><p>Critical Care 2008;12(1):R2-R2.…”
-
978
-
979
-
980